Company Information

WANBURY LTD.

NSE : WANBURYBSE : 524212ISIN CODE : INE107F01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE157.15-1.45 (-0.91 %)
PREV CLOSE ( ) 158.60
OPEN PRICE ( ) 160.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3605
TODAY'S LOW / HIGH ( )156.35 160.25
52 WK LOW / HIGH ( )41.2 177.4
NSE157.75-0.9 (-0.57 %)
PREV CLOSE( ) 158.65
OPEN PRICE ( ) 158.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 157.75 (98)
VOLUME 56435
TODAY'S LOW / HIGH( ) 156.10 160.90
52 WK LOW / HIGH ( )42.65 179.35
Company SecretaryJitendra J Gandhi
Vice ChairmanK Chandran
Non Executive Independent DirectorPravin Dilip Pawar
Incorporation Year : 1988

Registered Office :

Address : B S E L Tech Park,B - Wing, 10th Floor, Sector 30 A,Opp. Vashi Railway Station, Vashi Navi Mumbai,
Maharashtra-400705 .

Phone : 022-67942222 / 71963222

Email :  info@wanbury.com 

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,Luxembourg

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.